within Pharmacolibrary.Drugs.ATC.G;

model G04BX03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 0.00125,
    adminDuration  = 600,
    adminMass      = 250 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00066,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0009666666666666667,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G04BX03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Acetohydroxamic acid is a urease inhibitor used as an adjunctive treatment for chronic urea-splitting urinary tract infections, particularly caused by Proteus species. It is used in patients with chronic infections and high urinary pH to reduce the formation of struvite stones. The drug is no longer widely used due to potential adverse effects and is not a first-line therapy, but may still be available in some countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after single oral dose of acetohydroxamic acid.</p><h4>References</h4><ol><li><p>Feldman, S, et al., &amp; Griffith, DP (1978). Pharmacokinetics of acetohydroxamic acid. Preliminary investigations. <i>Investigative urology</i> 15(6) 498–501. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/649302/\">https://pubmed.ncbi.nlm.nih.gov/649302</a></p></li><li><p>Putcha, L, et al., &amp; Feldman, S (1985). Pharmacokinetics of acetohydroxamic acid in patients with staghorn renal calculi. <i>European journal of clinical pharmacology</i> 28(4) 439–445. DOI:<a href=\"https://doi.org/10.1007/BF00544364\">10.1007/BF00544364</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3928387/\">https://pubmed.ncbi.nlm.nih.gov/3928387</a></p></li><li><p>Putcha, L, et al., &amp; Feldman, S (1984). Disposition of 14C-acetohydroxamic acid and 14C-acetamide in the rat. <i>Drug metabolism and disposition: the biological fate of chemicals</i> 12(4) 438–443. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6148210/\">https://pubmed.ncbi.nlm.nih.gov/6148210</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G04BX03;
